How does Ella (ulipristal acetate) differ from Plan B (levonorgestrel) in terms of mechanism of action?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differences Between Ella (Ulipristal Acetate) and Plan B (Levonorgestrel)

Ella (ulipristal acetate) is more effective than Plan B (levonorgestrel) for emergency contraception, especially when taken 72-120 hours after unprotected intercourse and for women who are overweight or obese. 1

Mechanism of Action

Ella (Ulipristal Acetate)

  • Acts as a selective progesterone receptor modulator 2
  • Primary mechanism: Delays or inhibits ovulation even when taken shortly before ovulation 3
  • Has a direct inhibitory effect on follicular rupture 3
  • Effective on larger follicles (up to 18mm in diameter) 4
  • Works even when LH levels have begun to rise (advanced follicular phase) 2

Plan B (Levonorgestrel)

  • Acts as a progestin-only emergency contraceptive 5
  • Primary mechanism: Delays or inhibits ovulation 3
  • Only effective if taken before the LH surge begins 3
  • Only effective on smaller follicles (up to 14mm in diameter) 4
  • Ineffective when taken close to ovulation 3

Efficacy Comparison

  • Ulipristal acetate prevents approximately 85% of expected pregnancies 1
  • Levonorgestrel prevents approximately 75-80% of expected pregnancies 1
  • Meta-analysis shows ulipristal acetate has:
    • 42% lower pregnancy risk than levonorgestrel up to 72 hours after intercourse 5
    • 65% lower pregnancy risk in the first 24 hours after intercourse 5

Timing of Administration

  • Ella (Ulipristal Acetate):

    • Effective up to 120 hours (5 days) after unprotected intercourse 1, 5
    • Maintains effectiveness throughout the 5-day window 6
    • More effective than levonorgestrel between days 3-5 1
  • Plan B (Levonorgestrel):

    • FDA-approved for use up to 72 hours (3 days) after unprotected intercourse 5
    • Most effective when taken as soon as possible after intercourse 1
    • Efficacy decreases significantly after 72 hours 6

Special Considerations

Weight/BMI Impact

  • Ulipristal acetate is more effective than levonorgestrel for women who are overweight or obese 1

Dosing

  • Ella: Single 30mg dose 5
  • Plan B: Single 1.5mg dose (Plan B One-Step) or two 0.75mg pills taken 12 hours apart (Next Choice) 5

Availability

  • Ella requires a prescription in the United States 5
  • Plan B is available over-the-counter without age restrictions 7

Clinical Application Algorithm

  1. Determine time since unprotected intercourse:

    • If within 72 hours: Either method can be used, but ulipristal acetate is more effective
    • If between 72-120 hours: Ulipristal acetate is the only effective oral option
  2. Consider patient weight/BMI:

    • For patients with higher BMI: Ulipristal acetate is preferred
  3. Assess proximity to ovulation:

    • If close to ovulation: Ulipristal acetate is significantly more effective
  4. Check accessibility:

    • If prescription access is limited and immediate treatment needed: Plan B may be more accessible

Common Pitfalls to Avoid

  • Timing misconception: Don't assume both medications have the same window of effectiveness. Ella works up to 5 days, while Plan B is most effective within 3 days.

  • Efficacy overestimation: Neither method is 100% effective. Ulipristal acetate prevents about 85% of expected pregnancies, while levonorgestrel prevents about 75-80%.

  • Mechanism confusion: Both primarily work by delaying ovulation, not by preventing implantation of a fertilized egg.

  • Weight considerations: Both medications may be less effective in women with higher BMI, but ulipristal acetate maintains better efficacy in this population.

  • Repeated use: Neither medication should be used as regular contraception; they are designed for emergency use only.

References

Guideline

Contraception Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ulipristal acetate, a progesterone receptor modulator for emergency contraception.

Journal of pharmacology & pharmacotherapeutics, 2012

Research

Update on emergency contraception.

Advances in therapy, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.